Chromosomal translocation products engender new intracellular therapeutic technologies.
Chromosomal translocations occur in leukemias, lymphomas, sarcomas and some epithelial tumors and some generate unique fusion proteins. These translocation products may provide tumor-specific targets for the development of new therapeutic strategies tailored to a malignant cell.
Autori principali: | Rabbitts, T, Stocks, MR |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
2003
|
Documenti analoghi
Documenti analoghi
-
Chromosomal translocation master genes, mouse models and experimental therapeutics.
di: Rabbitts, T
Pubblicazione: (2001) -
Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.
di: Pérez-Martínez, D, et al.
Pubblicazione: (2010) -
Mouse models of human chromosomal translocations and approaches to cancer therapy.
di: Rabbitts, T, et al.
Pubblicazione: (2001) -
The promiscuous MLL gene links chromosomal translocations to cellular differentiation and tumour tropism.
di: Collins, E, et al.
Pubblicazione: (2002) -
The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion.
di: Nam, C, et al.
Pubblicazione: (2006)